There’s no vaccine. Treatment costs thousands. It affects 3.5 million Americans.
There were nearly 3,000 cases of acute hepatitis C reported to the CDC in 2016, and an estimated 3.5 million people in the U.S have chronic hepatitis C. Hepatitis C is a blood-borne pathogen, spreading through blood contact—such as sexual activity or drug use.
Currently, there is no vaccine for it—with treatment methods costing up to $1,000 per pill, according to Dr. Joseph Mester, associate biological sciences professor. Previously, Mester worked with vaccine trials for vaccine companies before coming to NKU.